Compounds > 3,4,5,3',4'-pentachlorobiphenyl
Page last updated: 2024-08-24

3,4,5,3',4'-pentachlorobiphenyl and Dyslipidemia

3,4,5,3',4'-pentachlorobiphenyl has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, Y; Dong, S; Huang, Q; Lin, Y; Lu, Y; Ye, G1

Other Studies

1 other study(ies) available for 3,4,5,3',4'-pentachlorobiphenyl and Dyslipidemia

ArticleYear
Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease.
    The Science of the total environment, 2019, Feb-25, Volume: 653

    Topics: Animals; Dysbiosis; Dyslipidemias; Female; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Polychlorinated Biphenyls

2019